Novartis names Mukul Mehta as CFO

Mukul Mehta succeeds Harry Kirsch, who has served as CFO since 2013.

By  Storyboard18Jul 18, 2025 6:49 AM
Novartis names Mukul Mehta as CFO
Mukul Mehta was recently appointed to the role of head of BPA, Digital Finance and Tax, which he will continue until March of next year.

Novartis appointed Mukul Mehta as the chief financial officer (CFO) and a member of the Executive Committee of Novartis (ECN), effective March 16, 2026. Mehta succeeds Harry Kirsch, who has served as CFO since 2013, and will retire from Novartis after a 22-year career with the company. Kirsch will continue in his role as CFO and member of the ECN until March 15, 2026.

Mehta brings over 20 years of experience at Novartis, having held key finance leadership roles across geographies and business units.

He was recently appointed to the role of head of BPA, Digital Finance and Tax, which he will continue until March of next year. His career includes serving as CFO International for three years, ad-interim President International, CFO Pharmaceuticals business unit, CFO Novartis Business Services, CFO Pharmaceuticals Europe business, and country CFO of France, Poland, and Norway.

“I am honored to take on the role of CFO at Novartis,” said Mehta. “I’ve had the privilege of growing with this company and working alongside exceptional colleagues. I look forward to continuing our journey as a focused medicines company and delivering sustainable value for patients and shareholders.”

“It has been a tremendous privilege to serve Novartis for the past 22 years. I am proud of the transformation we’ve led - from streamlining the company from six divisions to three, to the successful spinoffs of Alcon and Sandoz, and the divestitures of our stakes in the consumer healthcare joint venture with GSK and in Roche. Together, we’ve built a truly focused medicines company. I leave with deep gratitude for the teams I’ve worked with and have full confidence in Mukul’s leadership,” said Kirsch.

Vas Narasimhan, CEO, Novartis said, “Harry’s impact on Novartis has been profound. He played a pivotal role in driving what has so far been one of our strongest periods of growth and strategic transformation. Under Harry’s leadership, the company’s financial performance has significantly improved as evidenced by our strong balance sheet, improved core operating income margin, and robust free cash flow. I thank him for his unwavering commitment and wish him the very best in his next chapter. I am also looking forward to welcoming Mukul to the ECN. His deep knowledge of our business, strong financial expertise, and collaborative style position him well to guide our financial strategy and finance organization through our next phase of growth.”

Mehta holds a degree in Management from the Jamnalal Bajaj Institute of Management Studies in India and an MBA from INSEAD France.

First Published on Jul 18, 2025 6:49 AM

More from Storyboard18

Brand Makers

Reliance Retail acquires home appliance firm Kelvinator

Reliance Retail acquires home appliance firm Kelvinator

Brand Makers

EU delays Musk’s X probe amid U.S. trade talks

EU delays Musk’s X probe amid U.S. trade talks

Brand Makers

Apollo Tyres appoints R Mahalakshmi as CHRO

Apollo Tyres appoints R Mahalakshmi as CHRO

Brand Makers

Flipkart elevates Kanchan Mishra to lead mobiles and qcomm

Flipkart elevates Kanchan Mishra to lead mobiles and qcomm

Brand Makers

Karnataka defers action on RCB stampede, criminal charges loom for organizers

Karnataka defers action on RCB stampede, criminal charges loom for organizers

Brand Makers

'Regional is the buzzword today': Ashish Sehgal on why language-first content is the future of India

'Regional is the buzzword today': Ashish Sehgal on why language-first content is the future of India

Brand Makers

Meta elevates Connor Hayes to Head of Threads

Meta elevates Connor Hayes to Head of Threads